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Epithelial-mesenchymal transition (EMT) has emerged in recent years as an important process in the development of organ fibrosis
in many human diseases. Our previous experience in a nonhuman primate model of obstructive nephropathy suggested that EMT
of collecting duct epithelium contributes to the development of interstitial fibrosis. In this study we demonstrate for the first
time in humans that obstructed fetal collecting duct epithelium undergoes transition to mesenchymal phenotype, characterized
by decreased expression of epithelial markers, de novo expression of mesenchymal markers with subsequent loss of cell-cell
interaction, disruption of the basement membrane, and increased deposition of extracellular matrix into the expanded interstitium
of the obstructed kidney. The results of this study therefore support the previous findings from animal studies and suggest that
EMT of the collecting duct epithelium might contribute to the development of interstitial fibrosis in human fetal obstructive
nephropathy.
1. Introduction
Renal hypoplasia/dysplasia, often associated with obstructive
nephropathy, is the leading cause of end stage renal disease in
childhood [1]. Despite advances in diagnosis and antenatal
management of congenital urinary tract obstruction, the
outcomes of these children have not improved since fetal
intervention was introduced into clinical practice over 20
years ago.
Injury to the epithelium in a number of human disease
states causes epithelial cells to acquire mesenchymal charac-
teristics through the process of epithelial-mesenchymal tran-
sition (EMT), and in congenital urinary tract obstruction
this contributes to the characteristic tubulointerstitial disease
[2–7]. The hallmark of renal dysplasia is the accumulation
of extracellular matrix in the interstitium leading to fibrosis.
The injured epithelium plays an important role in this
process.
We have previously studied the pathogenesis of renal
dysplasia in a nonhuman primate model of obstructive
nephropathy [8, 9], and highlighted significant histo-
pathological changes in the renal medullary interstitium,
including dilatation of the collecting ducts (CDs), and
disruption of the CD epithelium. We have also defined
features suggestive of CD EMT in this experimental animal
model with loss of the normal epithelial phenotype, gain of a
mesenchymal phenotype, disruption of the tubular epithelial
basement membrane, and migration of the transformed cells
into the interstitium [10].
The aim of this study was to test the hypothesis that
congenital urinary tract obstruction in humans results in
CD epithelial cell injury and transition to a mesenchymal
phenotype, and that these transformed cells contribute to
interstitial fibrosis.
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Figure 1: Gestational and postnatal ages of the obstructed and control kidney tissue samples.
2. Materials and Methods
2.1. Tissue Samples. Specimens from obstructed and normal
human fetal and postnatal kidneys were studied (total n =
17). Obstructed kidney samples were obtained from fetuses
in the second (18 weeks gestation, n = 2) and third
trimesters (36 weeks gestation, n = 3), and postnatal ages
(16 and 24 months, n = 2). Controls consisted of kidney
samples from fetuses in the late first trimester (10 weeks,
n = 1), second trimester (15, 18 and 26 weeks, n = 6),
and third trimester (27 and 36 weeks gestation, n = 2),
and 12 months postnatal age (n = 1) (Figure 1). In all
cases fetuses had no other noted anomalies. Control kidney
samples were obtained from aborted fetuses and children
that died from causes unrelated to renal disease. All samples
were collected in accordance with the ethical guidelines of the
University of British Columbia, and all performed analyses
were approved by the Ethics Committee of the University of
British Columbia.
2.2. Tissue Processing. After collection, kidneys were sec-
tioned transversely and sagitally then immediately fixed in
4% paraformaldehyde overnight, and dehydrated through
graded ethanol before transfer to toluene. Sections of
paraffin-embedded tissue were cut with a microtome (5–
10 μm), mounted on Superfrost slides (VWR), and baked
overnight at 55◦C. Sections were then cooled to room
temperature and stored with desiccant. Samples for real-
time PCR were snap frozen in liquid nitrogen and stored at
≤ −80◦C.
2.3. Immunofluorescent Histochemistry. Tissue sections were
deparaffinized in xylene and rehydrated by passage through
graded ethanol. For light microscopy, sections were stained
with hematoxylin for 2 minutes and eosin for 40 seconds. For
immunohistochemistry, slides were subjected to 40 minutes
of heat-induced epitope retrieval in 10 mM citrate buffer
(pH 6–6.5). Sections were subsequently cooled to room
temperature and blocked for 1 hour with 2% goat or donkey
serum. Following blocking, excess buffer was removed from
the sections and replaced with diluted primary antibodies
in staining buffer for incubation overnight at 4◦C. Sections
were then incubated for 1 hour with fluorescently conjugated
secondary antibodies at room temperature. Nuclei were also
stained for 5 minutes with DAPI dilactate (1 : 36, Invitrogen)
prior to mounting with Prolong Gold mounting media
with antifade (Invitrogen). Analysis of tissue staining was
performed on a Leica epifluorescence microscope (Wetzlar,
Germany) using images captured with a Retiga 1300i camera
(QImaging, Canada) and processed with OpenLab imaging
software (Improvision, MA, USA). Primary antibodies and
their dilutions were as follows: anticytokeratin (DakoCy-
tomation, Carpinteria, CA), antiE-cadherin (BD Trans-
duction Laboratories, San Diego, CA), antiβ-catenin (Cell
Signalling Technology Danvers, MA), antiα-smooth muscle
actin, anticollagen IV (Fitzgerald Industries International
Inc., Concord, MA), and antivimentin (Sigma-Aldrich, Saint
Louis, MO) (all diluted 1 : 100). Secondary antibodies
included goat antimouse Alexa488, goat antirabbit Alexa568,
and donkey antigoat Alexa568 (Invitrogen Canada Inc.,
Canada) (all diluted 1 : 400). For correlation between
the degree of obstruction, and periductal α-SMA and CD
epithelial vimentin expression, we measured the areas of the
CD dilatation, the areas of α-SMA in periductal collars, and
the areas of the CD cells expressing vimentin (all expressed in
mm2) in obstructed fetal and postnatal kidneys (n = 3) using
the OpenLab imaging software. The relationship between
measured areas was expressed as a scatter plot with trend
lines using Microsoft Excel 2008 for Mac.
2.4. Real-Time PCR. Real-time PCR analysis was performed
on total RNA extracted from normal kidneys at 10 weeks
gestation (n = 1), 15 weeks gestation (n = 2), and 18
weeks gestation (n = 1), and obstructed kidneys at 18 weeks
gestation (n = 2) and 36 weeks gestation (n = 1). Total
RNA was isolated from the whole kidneys using RNeasy Mini
Kit protocol (Qiagen Inc., Mississauga, ON, Canada) with
RNA-free DNase treatment before treatment with Power-
Script reverse transcriptase (BD Biosciences, San Jose, CA).
Predesigned TaqMan Gene Expression Assays were used for
the following target genes: E-cadherin (Hs01013953 m1), N-
cadherin (Hs00983062 m1), α-catenin (Hs00426996 m1),
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Figure 2: Histological features of human fetal obstructive nephropathy. Obstructed 18 weeks gestation kidney shows disorganized cortical
architecture with multiple glomerular cysts (c), decreased glomerular (g) endowment ((b) and (f)), and reduced number and dilation of the
collecting ducts (cd) in the hypoplastic medulla ((d) and (h)). Cortex ((a) and (e)) and medulla ((c) and (g)) of a normal 18-week gestation
kidney. (a)–(d): hematoxylin and eosin stain; (e)–(h) immunofluorescence histochemistry: green = cytokeratin, red = vimentin. Scale bar =
100 μm.
β-catenin (Hs00355045 m1), vimentin (Hs00958116 m1),
alpha-3 chain of type IV collagen (Hs01022542 m1),
alpha-4 chain of type IV collagen (Hs01011885 m1), α-
smooth muscle actin (Hs00559403 m1), and cyclophilin A
(Hs99999904 m1) (Applied Biosystems, Foster City, CA).
All samples were amplified in triplicate on ABI Prism
7000 Sequence Detection System using TaqMan Universal
PCR MasterMix (Applied Biosystems, Foster City, CA).
Optimization and relative quantification were done using
the prevalidated comparative CT method. Normalization of
RNA quantity between samples was accounted for using the
expression of the housekeeping gene cyclophilin A. The fold
change of each gene between samples was determined relative
to control kidney at 18 weeks gestation.
3. Results
3.1. Histological Features of Human Congenital Obstructive
Dysplasia. Congenital urinary tract obstruction was associ-
ated with abnormal ureteric bud branching and defective
metanephric mesenchyme induction with subsequent abnor-
mal collecting duct, tubular, and glomerular development
(Figure 2). All obstructed developing kidneys showed focal
areas of dysplastic and cystic changes. Multiple glomerular
cysts were identified in both the cortex and the medulla,
whereas cystic dilatation of the renal tubules and CDs
was seen predominantly in the medulla (Figures 2(b) and
2(d)). The most pronounced dysplastic changes were seen
in the medullary regions of the obstructed kidneys where
some areas showed complete loss of normal structure
with dilated CDs surrounded by thick mesenchymal col-
lars. Other histopathological features of dysplasia included
decreased glomerular endowment, reduced number of CDs,
and medullary hypoplasia with interstitial expansion and
interstitial fibrosis. The most dilated CDs were lined with a
flattened epithelium (Figure 2). These changes were present
from early gestation and persisted postnatally.
3.2. Loss of Epithelial Phenotype in the Obstructed Collecting
Duct. The expression of the cytoskeletal proteins E-cadherin
and β-catenin was studied in normal and obstructed
human fetal kidneys. These proteins are important in
normal development of the kidney epithelium [11] and are
responsible for the maintenance of cell polarity, cell-cell
adhesion, and epithelial integrity [12]. In the normal human
CD epithelium, E-cadherin and β-catenin were expressed
early in gestation. Developmentally younger kidneys had
more pronounced cytoplasmic expression of both proteins
(Figure 3(a), inset), whereas kidneys from mid to late
gestation and postnatal kidneys showed colocalization of
E-cadherin and β-catenin at the intercellular junctions of
adjacent CD epithelial cells (Figures 3(b) and 3(c)). In
the obstructed kidneys, the disruption of E-cadherin-β-
catenin colocalization was noted, as well as a loss of E-
cadherin and β-catenin from the cellular membranes, and
the translocation of these proteins into the cytoplasm, with
E-cadherin identified in the nucleus of the injured CD
epithelial cells (Figures 3(d), 3(e), and 3(f)).
3.3. Gain of Mesenchymal Phenotype in the Obstructed
Collecting Duct. Injured epithelial cells undergoing EMT
express mesenchymal markers, including fibroblast-specific
protein-1, α-smooth muscle actin (α-SMA), and vimentin
[13]. We have previously demonstrated de novo α-SMA
expression in CD epithelial cells in the obstructed nonhuman
primate [10]. These cells contribute to the development
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Figure 3: E-cadherin and β-catenin immunoreactivity (IR). Normal kidneys ((a)–(c)). (a) In the early gestation kidney (10 weeks), E-cadherin-
IR (red) and β-catenin-IR (green) are localized in the cytoplasm (arrows). (b) Colocalization of E-cadherin-IR and β-catenin-IR (yellow)
to the intercellular junctions is well established by late gestation (27 weeks) (arrows), and (c) persists in the normal postnatal (12 months)
kidney (arrow). Obstructed kidneys ((d)–(f)). (d) Disruption of E-cadherin-IR and β-catenin-IR colocalization at the intercellular junctions,
with translocation of β-catenin-IR to the cytoplasm (green) and of E-cadherin-IR to the nucleus (red) (arrows in inset) in the (d) mid
gestation kidney (18 weeks), (e) late gestation kidney (36 weeks), and (f) postnatally (16 months kidney). Scale bar = 25 μm.
of immature mesenchymal collars surrounding the dilated
ducts. In the human fetal kidneys examined in this study,
the normal CD epithelium did not express α-SMA at any
stage of gestation or postnatally (Figures 4(a), 4(b), and
4(c)). However, we observed de novo α-SMA expression
in the obstructed epithelium at mid gestation, but not
later in gestation or postnatally (Figure 4(d)). Mid gestation
obstructed kidneys developed peritubular circumferential
cellular collars expressing α-SMA (Figure 4(d)), becoming
more pronounced as gestation progressed (Figure 4(e)). The
most extensive collars were observed in the inner medulla of
postnatal kidneys (Figure 4(f)) and also in the most severely
obstructed fetal kidneys. The severity of periductular tubular
collar formation correlated with the extent of epithelial
injury and the severity of the obstruction.
Vimentin, a member of the intermediate filament family
of proteins, offers flexibility to the cell while maintaining
cell shape and cytoskeletal integrity [14]. Under normal
circumstances, differentiated epithelial cells do not express
appreciable amounts of vimentin, whereas expression of
this protein is a characteristic feature of myofibroblasts. In
normal fetal kidneys, interstitial cells expressed vimentin,
which was most pronounced in younger gestation kidneys,
decreasing in later gestation, and almost absent in postnatal
kidneys (Figures 5(a), 5(b), and 5(c)). As expected, normal
CD epithelial cells did not express vimentin. However,
obstructed CD epithelial cells showed a very pronounced de
novo expression of vimentin that correlated with the severity
and the duration of the obstruction, increasing from mid
to late gestation and postnatally (Figures 5(d), 5(e), and
5(f)). Additionally, obstructed fetal kidneys developed an
expanded interstitium, which expressed abundant vimentin,
compared to normal kidneys of similar gestation. This was
more pronounced in younger kidneys.
3.4. Disruption of the Basement Membrane of the Obstructed
Collecting Duct. Type IV collagen (ColIV) is a major struc-
tural component of all basement membranes, including the
CD basement membrane. ColIV molecules are synthesized
by the cells attached to the basement membrane and are
subsequently incorporated into the membrane itself [15]. In
EMT, the disruption of basement membranes is necessary
to allow the migration of the transformed tubular epithelial
cells [4]. In this study, the CD epithelium of normal kidneys
expressed cytoplasmic ColIV diffusely at mid gestation and
apically at late gestation (Figures 5(a) and 5(b)). There was
no epithelial expression of ColIV in normal postnatal kidneys
(Figure 5(c)). Notably, and as expected, all normal fetal
and postnatal kidneys expressed ColIV in the CD basement
membranes in a thin, regular, and well-defined pattern
(Figures 5(a), 5(b), and 5(c)). In addition to an increase in
apical epithelial cell expression of ColIV, obstructed kidneys
demonstrated a marked disruption of the CD basement
membrane, characterized by thickening, attenuation, and
loss of ColIV expression (Figures 5(d), 5(e), 5(f)). Inter-
estingly, the expanded interstitium of the obstructed fetal
and postnatal kidneys expressed an abundance of ColIV,
most pronounced in the immature mesenchymal collars
surrounding the most dilated CDs, particularly in the inner
medulla of postnatal kidneys, suggesting a correlation with
the severity and duration of the obstruction (Figure 5(f)).
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Figure 4: E-cadherin and α-smooth muscle actin immunoreactivity. Normal kidneys ((a)–(c)). In the normal mid gestation (18 weeks) (a),
late gestation (27 weeks) (b), and postnatal (12 months) (c) kidneys, α-smooth muscle actin (α-SMA)-IR (green) was absent in the CD
epithelium; however, intercellular localization of E-cadherin-IR (red) was well established from mid gestation onwards (arrows). Obstructed
kidneys ((d)–(f)). Circumferential collars expressing α-SMA-IR (green) are present in the (d) mid gestation (18 weeks), (e) late gestation (36
weeks), and (f) postnatal (16 months) kidneys (arrows). De novo expression of α-SMA-IR in the obstructed CD epithelium is present at 18
weeks gestation ((d) inset, arrowhead) but not in the late gestation (e) or postnatal (f) kidneys. As in Figure 3, E-cadherin expression (red)
is disrupted, with translocation from the cell membrane to cytoplasm ((d)–(f)) and to the nucleus ((e) inset, arrowhead). Scale bar = 25 μm.
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Figure 5: Vimentin and collagen IV immunoreactivity. Normal kidneys ((a)–(c)). (a) Interstitial expression of vimentin-IR (blue) (arrow) and
diffuse cytoplasmic expression of collagen IV (ColIV)-IR (red) (arrowhead) are present in the mid gestation (18 weeks) kidney. (b) Thin,
regular, well-defined expression of ColIV-IR in the CD basement membranes (arrows) is well established by late gestation (27 weeks), and (c)
persists postnatally (12 months) (arrows). Obstructed kidneys ((d)–(f)). (d) De novo basolateral expression of vimentin-IR (blue) (arrow) in
the CD epithelium of the obstructed 18 weeks gestation kidney. (e) More pronounced vimentin-IR expression (arrowheads) and disruption
of ColIV-IR expression (red) (arrows) in the CD basement membrane of the late gestation (36 weeks) obstructed CD epithelium, and (f) in
the obstructed postnatal (16 months) kidneys. Deposition of ColIV-IR in the expanded interstitium (asterisk), and in the periductal collars
(plus) is also present. Scale bar = 25 μm.
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Figure 6: Correlation of the severity of CD dilatation with periductal collar formation and with CD epithelial vimentin expression. The
relationship between CD dilatation (x-axis), and the areas of periductal collars expressing α-SMA (a) and of CD epithelium expressing
vimentin (b) (y-axis) is shown. Measurements were performed in obstructed fetal (36 weeks gestation) and postnatal (16 months) kidneys
(n = 3). All areas are expressed in mm2.
To show the relationship between the severity of obstruc-
tion and the extent of phenotypic transition of the CD
epithelium, we correlated CD dilatation (as a marker of
severity of obstruction) with the expression of α-SMA in
periductal collars and of vimentin by the CD cells (as markers
of epithelial injury). CD dilatation correlated with periductal
α-SMA expression and with CD epithelial cell vimentin
expression (Figure 6).
3.5. Gene Expression in Obstructed Fetal Kidneys. Quan-
titative real-time PCR analysis was performed for genes
encoding epithelial and mesenchymal proteins of interest
on total RNA samples obtained from normal (early to mid
gestation) and obstructed (mid to late gestation) whole
kidneys. First, we studied normal changes in gene expression
with advancing gestation. Among genes encoding epithelial
proteins, E-cadherin mRNA expression increased in the 18
versus 10 weeks gestation kidneys, with little change in α-
catenin, β-catenin, and N-cadherin expression (Figure 7(a)).
For genes encoding mesenchymal proteins, vimentin, alpha-
3 and alpha-4 chains of ColIV, and α-SMA were all increased
in the normal 18 weeks compared to 10 weeks gestation
kidney (Figure 7(a)).
We next studied changes in the mRNA expression of
genes encoding epithelial and mesenchymal proteins in
mid (18 weeks) and late gestation (36 weeks) obstructed
kidneys, using the 18-week gestation normal kidney as the
reference control value. Of the genes encoding epithelial
proteins, N-cad expression decreased in the late gestation
obstructed kidney, while α-catenin and β-catenin mRNA
increased (Figure 7(b)). For genes encoding mesenchymal
proteins, vimentin mRNA expression increased with severe
obstruction at 18 and 36 weeks gestation, while mRNAs
for alpha-3, alpha-4 chains of ColIV and for α-SMA were
markedly increased in the severely obstructed 36-week
gestation kidney when compared to the control normal 18
week kidney (Figure 7(b)).
4. Discussion
Epithelial-mesenchymal transition (EMT) and the recip-
rocal mesenchymal-epithelial transition (MET) are central
mechanisms in the development of specialized cells, tissues
and organs from a small variety of pluripotent cells in the
embryo [2, 16]. Experimental evidence that has accumulated
over the last decade supports the role of EMT in the
pathogenesis of many diseases including cancer progression
and metastasis [17], and tissue fibrosis associated with
interstitial lung [18, 19], liver [20], and kidney disease [4,
5, 7]. The role of EMT has been demonstrated in animal
and human studies of postnatal kidney disease, including
acquired obstructive nephropathy [21], but there are few data
regarding congenital urinary tract obstruction.
Many experimental models of obstructive nephropathy
have been developed [22]. These have provided clues to
the pathogenesis and pathology of this disease. However,
there are some important differences between the human
congenital forms of obstruction and experimental models.
In human congenital urinary tract obstruction, the timing
of obstruction is often early during in utero nephrogenesis
as opposed to experimental models, such as the sheep and
monkey models, which are mid to late gestation. The best-
described models of ureteric obstruction, the mouse and rat,
are, in fact, postnatal models. In addition, the severity of
obstruction differs. Congenital obstruction can be variable,
from severe and complete to mild and partial obstruction.
Most experimental models are more controlled and there-
fore reproducible. Consequently, the histopathology of the
human forms of congenital obstruction can be variable
(partly due to uncontrollable variability of the timing and
severity of obstruction and partly to the inherent bias of the
availability of tissue) but given the early onset of obstruction,
it is often more severe than that of the experimental forms
of postnatal obstruction, particularly the postnatal rodent
models, as reflected in the severity of architectural disruption
and reduction in glomerular number. There are, however,
many histological features shared between both types of
Journal of Biomedicine and Biotechnology 7
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Figure 7: Gene expression in normal and obstructed fetal kidneys. (a) Quantitative PCR analysis of total RNA extracted from 10, 15, and 18
weeks gestation normal kidneys, for genes encoding epithelial-specific (E-cad, N-cad, α-cat, and β-cat) and mesenchymal-specific (vimentin,
ColIVa3, ColIVa5 and α-SMA) proteins. Values are expressed as fold change in mRNA expression compared to the normal 10 weeks gestation
kidney as reference. (b) Quantitative PCR analysis of total RNA extracted from obstructed kidneys at 18 weeks gestation (mild and severe)
and 36 weeks gestation (severe), and from 18 weeks normal kidney. Values are expressed as fold change in mRNA expression compared to
the normal 18 weeks gestation kidney as reference.
obstruction, most notably human congenital obstruction
and in utero models of obstruction such as the sheep and
monkey models. These features include extensive reductions
in nephron endowment, alterations of tubular and collecting
duct development, collecting duct injury, mesenchymal
expansion, and interstitial fibrosis.
This report, to our knowledge, is the first description of
the phenotypic transition of the obstructed CD epithelium
in the human fetus. We have previously described EMT
of the obstructed CD epithelium in a nonhuman primate
model of obstructive nephropathy [10]. Similar to the
obstructed fetal monkey kidney, the major histological
findings in the obstructed human fetal kidney were cystic
and dysplastic changes particularly in the medulla, with
marked dilatation of the CDs lined by a flattened epithelium.
We also demonstrated many of the prerequisite features of
CD EMT, including the loss of the cytoskeletal proteins E-
cadherin and β-catenin from cell membranes and intercel-
lular junctions, their translocation into the cytoplasm and
nucleus of the obstructed cells, de novo expression of the
myoepithelial proteins vimentin and α-SMA, and disruption
of the obstructed CD epithelial basement membrane. As
documented by immunohistochemistry in this study, from
early gestation, CD cells express epithelial markers (E-
cadherin, β-catenin) in an intercellular distribution typical
of a differentiated epithelium with minimal expression of
mesenchymal proteins, such as vimentin and α-smooth
muscle actin. These findings confirm that the cells have
undergone MET. The loss of normal distribution of epithelial
markers and de novo expression of mesenchymal proteins
by CD cells in obstructed kidneys imply that obstruction
reverses this process. While these findings may not be
inclusive of all features of EMT, they do represent a transition
to a more mesenchymal phenotype. Our findings would
suggest that this transition can occur in cells that have
not terminally differentiated. We have also shown that CD
dilatation correlated with periductal α-SMA expression and
with CD epithelial cell vimentin expression. While we were
able to demonstrate a clear correlation in the most severely
affected areas, it is important to note that the histopathology
and injury in congenital obstructive nephropathy can be
variable and focal. We observed areas of severe dysplastic
changes alternating with areas of nearly normal histology
within the same obstructed kidney. It is therefore very
difficult to assign any grading to the whole kidney.
The results of real-time PCR analysis show a marked
increase in genes encoding mesenchymal proteins and
minimal changes in genes encoding epithelial proteins in
obstructed kidneys. It should be noted that we used total
RNA extracted from whole kidneys for these experiments.
CD epithelial RNA constitutes only a small fraction of
the whole kidney RNA. The increase in genes encoding
mesenchymal proteins likely reflects mesenchymal expansion
and the formation of periductal collars, measures of whole
kidney fibrosis, with only a small contribution from the
dilated CD epithelial RNA. While the whole kidney fibrosis
may be independent of the parallel changes seen in the
injured CD epithelium, there is experimental evidence
supporting the contribution of the obstructed tubular
epithelium to this process [3]. The minimal changes in genes
encoding epithelial proteins in the obstructed CDs may be
explained again by the relatively small contribution of CD
8 Journal of Biomedicine and Biotechnology
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Figure 8: Paradigm of changes associated with human congenital urinary tract obstruction. The obstruction of the developing kidneys causes
dissociation of the cytoskeletal proteins (E-cadherin, β-catenin) and their translocation to the cytoplasm and the nucleus. Affected cells
become flattened and start expressing mesenchymal markers (vimentin, α-SMA) giving them more flexibility and contractility. Breakdown
of the ductal basement membrane allows the cells to migrate into the interstitium and to contribute to the myoepthelial population of
periductal cells.
RNA relative to total kidney RNA. The other possibility
is that there are minimal changes in RNA levels in the
obstructed CD epithelium, supported by our immunohisto-
chemistry, demonstrating altered cellular protein localization
rather then a decrease in total protein expression.
The sequence of changes seen in EMT is very similar
irrespective of the organ involved. The earliest epithelial
responses to injury include the loss of intercellular adhesion
molecules (E-cadherin, ZO-1) and dissociation of these
and other structural anchoring molecules (catenins) from
the cytoskeleton of the cell leading to a detachment of
the cells from each other, and to their loss of polarity.
Reorganization of the actin cytoskeleton, conversion of
cytokeratin to vimentin, and de novo expression of α-smooth
muscle actin, the main features of transition into a myofi-
broblastic phenotype, provide the transitioning cells with
more flexibility and mobility. Vimentin offers the cells more
flexibility while maintaining the cell shape and the position
of organelles in the cytoplasm [23]. α-SMA provides not only
structural support but also the element of contractility that
can help in the invasiveness of the transformed cells [24].
Breakdown of type IV collagen and laminin in the tubular
basement membrane opens the path for these invasive cells
to enter the interstitium and become interstitial fibroblasts
[24, 25]. The final nonspecific pathway of this process
is the development of tissue fibrosis and destruction of
tissue architecture, leading to organ dysfunction and failure
(Figure 8). On the other hand, if the disease process is inter-
rupted, phenotypically transformed cells can redifferentiate
back into epithelial cells and contribute to the tissue repair,
thus undergoing so-called epithelial-mesenchymal-epithelial
cycling [26].
5. Conclusion
This study describes the phenotypic changes in human
congenital obstructive nephropathy. It represents another
step in our understanding of the pathogenesis of this
Journal of Biomedicine and Biotechnology 9
disease and brings us closer to the identification of the key
genes/proteins that play an important role in this condition.
Elucidating the role of the individual proteins in EMT will
guide the development of targeted treatments to reverse
tissue fibrosis and eventually prevent the damage of the
affected organ.
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